Cargando…
Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146401/ https://www.ncbi.nlm.nih.gov/pubmed/21726450 http://dx.doi.org/10.1186/1532-429X-13-33 |
_version_ | 1782209200816914432 |
---|---|
author | Mohrs, Oliver K Wunderlich, Nina Petersen, Steffen E Pottmeyer, Anselm Kauczor, Hans-Ulrich |
author_facet | Mohrs, Oliver K Wunderlich, Nina Petersen, Steffen E Pottmeyer, Anselm Kauczor, Hans-Ulrich |
author_sort | Mohrs, Oliver K |
collection | PubMed |
description | BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4 PLAATO; n = 2 Watchman; n = 1 ACP) underwent 2 contrast-enhanced (Gd-DOTA) CMR sequences (2D TrueFISP first-pass perfusion and 3D-TurboFLASH) to assess localization, artifact size and potential leaks of the devices. Perfusion CMR was analyzed visually and semi-quantitatively to identify potential leaks. RESULTS: All occluders were positioned within the LAA. The ACP occluder presented the most extensive artifact size. Visual assessment revealed a residual perfusion of the LAA apex in 4 cases using first-pass perfusion and 3D-TurboFLASH indicating a suboptimal LAA occlusion. By assessing signal-to-time-curves the cases with a visually detected leak showed a 9-fold higher signal-peak in the LAA apex (567 ± 120% increase from baseline signal) than those without a leak (61 ± 22%; p < 0.03). In contrast, the signal increase in LAA proximal to the occluder showed no difference (leak 481 ± 201% vs. no leak 478 ± 125%; p = 0.48). CONCLUSION: This CMR pilot study provides valuable non-invasive information in patients after transcatheter occlusion of the LAA to identify correct placement and potential leaks. We recommend incorporating CMR in future clinical studies to evaluate new device types. |
format | Online Article Text |
id | pubmed-3146401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31464012011-07-30 Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study Mohrs, Oliver K Wunderlich, Nina Petersen, Steffen E Pottmeyer, Anselm Kauczor, Hans-Ulrich J Cardiovasc Magn Reson Research BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4 PLAATO; n = 2 Watchman; n = 1 ACP) underwent 2 contrast-enhanced (Gd-DOTA) CMR sequences (2D TrueFISP first-pass perfusion and 3D-TurboFLASH) to assess localization, artifact size and potential leaks of the devices. Perfusion CMR was analyzed visually and semi-quantitatively to identify potential leaks. RESULTS: All occluders were positioned within the LAA. The ACP occluder presented the most extensive artifact size. Visual assessment revealed a residual perfusion of the LAA apex in 4 cases using first-pass perfusion and 3D-TurboFLASH indicating a suboptimal LAA occlusion. By assessing signal-to-time-curves the cases with a visually detected leak showed a 9-fold higher signal-peak in the LAA apex (567 ± 120% increase from baseline signal) than those without a leak (61 ± 22%; p < 0.03). In contrast, the signal increase in LAA proximal to the occluder showed no difference (leak 481 ± 201% vs. no leak 478 ± 125%; p = 0.48). CONCLUSION: This CMR pilot study provides valuable non-invasive information in patients after transcatheter occlusion of the LAA to identify correct placement and potential leaks. We recommend incorporating CMR in future clinical studies to evaluate new device types. BioMed Central 2011-07-04 /pmc/articles/PMC3146401/ /pubmed/21726450 http://dx.doi.org/10.1186/1532-429X-13-33 Text en Copyright ©2011 Mohrs et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Mohrs, Oliver K Wunderlich, Nina Petersen, Steffen E Pottmeyer, Anselm Kauczor, Hans-Ulrich Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title_full | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title_fullStr | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title_full_unstemmed | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title_short | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study |
title_sort | contrast-enhanced cmr in patients after percutaneous closure of the left atrial appendage: a pilot study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146401/ https://www.ncbi.nlm.nih.gov/pubmed/21726450 http://dx.doi.org/10.1186/1532-429X-13-33 |
work_keys_str_mv | AT mohrsoliverk contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy AT wunderlichnina contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy AT petersensteffene contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy AT pottmeyeranselm contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy AT kauczorhansulrich contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy |